Same Drug Class

Imatinib vs Ipilimumab

Imatinib vs Ipilimumab: Overview

This comparison examines the pharmacological differences between Imatinib and Ipilimumab.

Mechanism of Action

Imatinib: Selective inhibitor of BCR-ABL, c-Kit, and PDGFR tyrosine kinases.

Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.

Pharmacokinetics

Half-life: Imatinib — 18 hours; Ipilimumab — 14.7 days.

Chemical Properties

Molecular Formula: Imatinib — C29H31N7O.

Molecular Weight: Imatinib — 493.6030 g/mol.

Type: Imatinib — Small molecule; Ipilimumab — Antibody.